The Course of COVID-19 in Four Patients with HIV During the Pandemic

被引:4
作者
Turken, Melda [1 ]
Altan, Hividar [1 ]
Atalay, Sabri [1 ]
Kose, Sukran [1 ]
机构
[1] Univ Hlth Sci, Izmir Tepecik Training & Res Hosp, Dept Infect Dis & Clin Microbiol, Yenisehir, Izmir, Konak, Turkey
关键词
CD4; coagulopathy; COVID-19; HIV; pandemic; retinal degenaration; SARS-CoV-2;
D O I
10.2174/1570162X18666201201093540
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: The clinical spectrum of SARS-CoV-2 infection may vary from simple colds to a severe acute respiratory syndrome, metabolic acidosis, septic shock, and multiple organ failure. Current evidence indicates that the risk of severe illness increases with age, in the male sex, and with certain chronic medical problems. Many people living with HIV have other conditions that increase their risk. Case presentation: In the first 3 months of the pandemic, four patients with HIV were hospitalized in our clinic because of COVID-19. The disease severity was mild in two patients with normal CD4+ T count. However, one patient with a low CD4+T count died and the other developed retinal detachment one month after discharge. The deceased patient had a malignancy. Conclusion: In this study, the effect of the immunological status of the patients on the course of COVID-19 and the developing vascular complications was evaluated in 4 patients with HIV.
引用
收藏
页码:286 / 291
页数:6
相关论文
共 43 条
  • [1] Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
    Arshad, Samia
    Kilgore, Paul
    Chaudhry, Zohra S.
    Jacobsen, Gordon
    Wang, Dee Dee
    Huitsing, Kylie
    Brar, Indira
    Alangaden, George J.
    Ramesh, Mayur S.
    McKinnon, John E.
    O'Neill, William
    Zervos, Marcus
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 97 : 396 - 403
  • [2] Axfors C, 2020, medRxiv, DOI [10.1101/2020.09.16.20194571, 10.1101/2020.09.16.20194571, DOI 10.1101/2020.09.16.20194571]
  • [3] COVID-19 in patients with HIV: clinical case series
    Blanco, Jose L.
    Ambrosioni, Juan
    Garcia, Felipe
    Martinez, Esteban
    Soriano, Alex
    Mallolas, Josep
    Miro, Jose M.
    [J]. LANCET HIV, 2020, 7 (05): : E314 - E316
  • [4] Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
  • [5] Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants
    Catteau, Lucy
    Dauby, Nicolas
    Montourcy, Marion
    Bottieau, Emmanuel
    Hautekiet, Joris
    Goetghebeur, Els
    van Ierssel, Sabrina
    Duysburgh, Els
    Van Oyen, Herman
    Wyndham-Thomas, Chloe
    Van Beckhoven, Dominique
    Bafort, Kristof
    Belkhir, Leila
    Bossuyt, Nathalie
    Caprasse, Philippe
    Colombie, Vincent
    De Munter, Paul
    Deblonde, Jessika
    Delmarcelle, Didier
    Delvallee, Melanie
    Demeester, Remy
    Dugernier, Thierry
    Holemans, Xavier
    Kerzmann, Benjamin
    Machurot, Pierre Yves
    Minette, Philippe
    Minon, Jean-Marc
    Mokrane, Saphia
    Nachtergal, Catherine
    Noirhomme, Severine
    Pierard, Denis
    Rossi, Camelia
    Schirvel, Carole
    Sermijn, Erica
    Staelens, Frank
    Triest, Filip
    Van Goethem, Nina
    Van Praet, Jens
    Vanhoenacker, Anke
    Verstraete, Roeland
    Willems, Elise
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (04)
  • [6] Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
    Cavalcanti, A. B.
    Zampieri, F. G.
    Rosa, R. G.
    Azevedo, L. C. P.
    Veiga, V. C.
    Avezum, A.
    Damiani, L. P.
    Marcadenti, A.
    Kawano-Dourado, L.
    Lisboa, T.
    Junqueira, D. L. M.
    de Barros e Silva, P. G. M.
    Tramujas, L.
    Abreu-Silva, E. O.
    Laranjeira, L. N.
    Soares, A. T.
    Echenique, L. S.
    Pereira, A. J.
    Freitas, F. G. R.
    Gebara, O. C. E.
    Dantas, V. C. S.
    Furtado, R. H. M.
    Milan, E. P.
    Golin, N. A.
    Cardoso, F. F.
    Maia, I. S.
    Hoffmann Filho, C. R.
    Kormann, A. P. M.
    Amazonas, R. B.
    Bocchi de Oliveira, M. F.
    Serpa-Neto, A.
    Falavigna, M.
    Lopes, R. D.
    Machado, F. R.
    Berwanger, O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (21) : 2041 - 2052
  • [7] Chen C., 2020, FAVIPIRAVIR VERSUS A, DOI 10.1101/2020.03.17.20037432
  • [8] Clinical and immunological features of severe and moderate coronavirus disease 2019
    Chen, Guang
    Wu, Di
    Guo, Wei
    Cao, Yong
    Huang, Da
    Wang, Hongwu
    Wang, Tao
    Zhang, Xiaoyun
    Chen, Huilong
    Yu, Haijing
    Zhang, Xiaoping
    Zhang, Minxia
    Wu, Shiji
    Song, Jianxin
    Chen, Tao
    Han, Meifang
    Li, Shusheng
    Luo, Xiaoping
    Zhao, Jianping
    Ning, Qin
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05) : 2620 - 2629
  • [9] Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03
  • [10] Chen L, 2020, medRxiv, DOI [10.1101/2020.06.19.20136093, 10.1101/2020.06.19.20136093, DOI 10.1101/2020.06.19.20136093]